BAXTER 5% GLUCOSE INTRAVENOUS INFUSION glucose 1000mL bag

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

glucose, Quantity: 45 g (Equivalent: glucose monohydrate, Qty 50 g)

Available from:

Baxter Healthcare Pty Ltd

INN (International Name):

glucose

Pharmaceutical form:

Injection

Composition:

Excipient Ingredients: water for injections

Administration route:

Intravenous

Units in package:

1 x 1000 mL bag

Prescription type:

Not scheduled. Not considered by committee

Therapeutic indications:

Glucose (5%) Intravenous Infusions are mainly indicated: - Whenever non-electrolyte fluid replacement is required. - As a vehicle for drug delivery, provided that the added components are compatible with glucose.

Product summary:

Visual Identification: Clear, colourless solution, practically free from visible particles; Container Type: Bag; Container Material: Plastic; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Authorization status:

Licence status A

Authorization date:

2011-09-15

Patient Information leaflet

Page 1 of 2
5% GLUCOSE INTRAVENOUS INFUSION
IN AVIVA PLASTIC CONTAINER (BAG)
CONSUMER MEDICINE INFORMATION
WHAT IS IN THIS LEAFLET
This leaflet answers some of
the common questions about 5%
Glucose Intravenous Infusion
(IVI) in AVIVA bags. It does not
contain all the available
information. It does not take the
place of talking to your doctor or
pharmacist.
All medicines have risks and
benefits. Your doctor has
weighed the risks of you being
given 5% Glucose IVI against
the benefits they expect it will
have for you.
IF YOU HAVE ANY CONCERNS
ABOUT THIS MEDICINE, ASK YOUR
DOCTOR OR PHARMACIST.
KEEP THIS LEAFLET. You may
need to read it again.
WHAT 5% GLUCOSE IVI IS
USED FOR
5% Glucose IVI is used for
whenever non-electrolyte fluid
replacement is required. This
product may also be used to
reconstitute and delivering other
drug products.
BEFORE YOU ARE GIVEN
5% GLUCOSE IVI
_ _
_5% GLUCOSE IVI SHOULD NOT BE _
_GIVEN TO YOU IF: _

you have an allergy to corn
or corn products, or any
ingredient listed at the end
of this leaflet. Some of the
symptoms of an allergic
reaction may include skin
rash, itching or hives,
shortness of breath,
wheezing or difficulty
breathing, swelling of the
face, lips, tongue or other
parts of the body;

you already have too much
glucose in your blood;

you had an ischaemic
stroke episode or head
trauma within 24 hours.
_5% GLUCOSE IVI SHOULD NOT BE _
_USED: _

if the solution is not clear;

if the packaging is torn or
shows sign of tampering;

after the expiry date printed
on the pack;

through the same tubing as
those containing blood.
_TELL YOUR DOCTOR IF:_

you have any allergies to any
medicines, foods,
preservatives or dyes;

you have head injury, stroke,
heart disease, renal
impairment, fluid/electrolyte
imbalance,
infection,
impaired glucose tolerance
or diabetes, vitamin B1
(thiamine) deficiency or
chronic alcoholism, and any
other illness;

you are pregnant or intend to
become pregnant or breast
feeding;

you are taking any
medications for diabetes, or

Summary of Product characteristics

Glucose Intravenous Infusion (Aviva bag)
Product Information
5% Glucose Intravenous Infusion AVIVA (ccsi43020131101) 27 May 2014
Page
1
of
9
Baxter Healthcare
5% GLUCOSE INTRAVENOUS INFUSION
IN AVIVA PLASTIC CONTAINER
NAME OF THE MEDICINE
COMPOSITION
The active ingredient is Glucose (anhydrous) in Water for Injections.
CHEMICAL STRUCTURE/ MOLECULAR FORMULA
The chemical name of glucose is (+)-D- glucopyranose. Molecular
formula of glucose is C
6
H
12
O
6.
C
6
H
12
O
6;
Molecular Weight = 180.2
CAS: 50-99-7
_ _
DESCRIPTION
Glucose is a monosaccharide, having physical characteristics as a
white or almost white, crystalline powder,
freely soluble in water, sparingly soluble in ethanol (96 per cent).
The Glucose 5.0% Intravenous Infusions are
clear, colourless solutions, practically free from visible particles
and are sterile, non-pyrogenic parenteral
solutions. The concentrations of glucose dissolved in a litre of Water
for Injections are shown in Table 1 (see
PRESENTATION AND STORAGE CONDITIONS
). They do not contain an antimicrobial agent or added buffer and have
a
ph of 3.2 - 6.5 for 5% glucose concentrations.
The isotonicity of these preparations is shown in Table 1 (
PRESENTATION AND STORAGE CONDITIONS)
. The Glucose
5% Intravenous Infusion is an isotonic solution.
PHARMACOLOGY
_Mechanism of Action _
Glucose is readily metabolised into carbon dioxide and water, with a
release of energy. As such, an administration
of a glucose solution either by oral or parenteral route provides
water for body hydration as well as calories. In
addition, it may reduce catabolic loss of nitrogen from the body and
aids in prevention of depletion of liver
glycogen. That is, in the absence of glucose, amino acids undergo
deamination. It is followed by oxidation, with a
release of energy. Thus, the Glucose 5.0% Intravenous Infusions has
value as a source of water and energy.
Glucose is readily converted into fat in the body which can be used as
a source of energy as required. Under a
similar conversion into storage of energy, glucose i